Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emily Schupfer"'
Autor:
Emily Schupfer, Soo Liang Ooi, Thomas C. Jeffries, Shaoyu Wang, Peter S. Micalos, Sok Cheon Pak
Publikováno v:
Molecules, Vol 28, Iss 14, p 5400 (2023)
This study investigated the effects of a modified rice bran arabinoxylan compound (RBAC) as a dietary supplement on the gut microbiota of healthy adults. Ten volunteers supplemented their diet with 1 g of RBAC for six weeks and 3 g of RBAC for anothe
Externí odkaz:
https://doaj.org/article/d6615f6c24d641c98328c3f88923ca05
Autor:
Soo Liang Ooi, Sok Cheon Pak, Peter S. Micalos, Emily Schupfer, Rob Zielinski, Thomas Jeffries, Garth Harris, Terry Golombick, David McKinnon
Publikováno v:
Contemporary Clinical Trials Communications, Vol 19, Iss , Pp 100580- (2020)
Introduction: Rice bran arabinoxylan compound (RBAC) is a nutraceutical for enhancing a depleted immune system during and after cancer treatment. This pilot feasibility trial aims to evaluate the effects of RBAC on cancer patients' quality of life du
Externí odkaz:
https://doaj.org/article/814fae8eb62e4e8c939107049afdfaf5
Autor:
Soo Liang Ooi, Sok Cheon Pak, Peter S. Micalos, Emily Schupfer, Catherine Lockley, Mi Houn Park, Sung-Joo Hwang
Publikováno v:
Molecules, Vol 26, Iss 9, p 2539 (2021)
Rice bran arabinoxylan compound (RBAC) is derived from defatted rice bran hydrolyzed with Lentinus edodes mycelial enzyme. It has been marketed as a functional food and a nutraceutical with health-promoting properties. Some research has demonstrated
Externí odkaz:
https://doaj.org/article/906a3abc2378474787758ea2a51a6c3f
Autor:
Peter S. Micalos, Garth Harris, Terry Golombick, Soo Liang Ooi, Emily Schupfer, Emad M. El-Omar, Shaoyu Wang, Thomas C. Jeffries, Sok Cheon Pak
Publikováno v:
Food Bioscience. 43:101267
Prebiotics are a class of functional foods which target beneficial microbial species of the gut to benefit host health. They consist of dietary fibres which, after ingestion, are degraded and fermented by microorganisms in the colon. Arabinoxylan (AX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::108cd818abc70ff319e54b16021403d0
https://doi.org/10.1016/j.fbio.2021.101267
https://doi.org/10.1016/j.fbio.2021.101267
Autor:
Sok Cheon Pak, Garth Harris, Soo Liang Ooi, Terry Golombick, Thomas C. Jeffries, Peter S. Micalos, Robert Zielinski, Emily Schupfer, David H. McKinnon
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100580-(2020)
Contemporary Clinical Trials Communications, Vol 19, Iss, Pp 100580-(2020)
Introduction Rice bran arabinoxylan compound (RBAC) is a nutraceutical for enhancing a depleted immune system during and after cancer treatment. This pilot feasibility trial aims to evaluate the effects of RBAC on cancer patients' quality of life dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575065089b9e93b8b1d1a76c8305f763
https://doi.org/10.1016/j.conctc.2020.100580
https://doi.org/10.1016/j.conctc.2020.100580